{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:40:23Z","timestamp":1791200423092,"version":"4.2.0"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2016,1,11]],"date-time":"2016-01-11T00:00:00Z","timestamp":1452470400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0146654","type":"journal-article","created":{"date-parts":[[2016,1,11]],"date-time":"2016-01-11T13:53:08Z","timestamp":1452520388000},"page":"e0146654","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":98,"title":["Inhibition of Aerobic Glycolysis Attenuates Disease Progression in Polycystic Kidney Disease"],"prefix":"10.1371","volume":"11","author":[{"given":"Meliana","family":"Riwanto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarika","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilka","family":"Edenhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Segerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf P.","family":"W\u00fcthrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,1,11]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","article-title":"Autosomal dominant polycystic kidney disease","volume":"369","author":"VE Torres","year":"2007","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMcp0804458","article-title":"Clinical practice. Autosomal dominant polycystic kidney disease","volume":"359","author":"JJ Grantham","year":"2008","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJMoa0907419","article-title":"Sirolimus and kidney growth in autosomal dominant polycystic kidney disease","volume":"363","author":"AL Serra","year":"2010","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/j.transproceed.2010.07.008","article-title":"Impact of mammalian target of rapamycin inhibition on autosomal-dominant polycystic kidney disease","volume":"42","author":"RP Wuthrich","year":"2010","journal-title":"Transplantation proceedings"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/MNH.0b013e3283621510","article-title":"Osmoregulation, vasopressin, and cAMP signaling in autosomal dominant polycystic kidney disease","volume":"22","author":"O Devuyst","year":"2013","journal-title":"Current opinion in nephrology and hypertension"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1681\/ASN.2013040398","article-title":"Strategies targeting cAMP signaling in the treatment of polycystic kidney disease","volume":"25","author":"VE Torres","year":"2014","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1517\/14656566.2014.903923","article-title":"Pharmacological management of polycystic kidney disease","volume":"15","author":"RP Wuthrich","year":"2014","journal-title":"Expert opinion on pharmacotherapy"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nm.3092","article-title":"Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy","volume":"19","author":"I Rowe","year":"2013","journal-title":"Nat Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1681\/ASN.2005060601","article-title":"Missense mutation in sterile alpha motif of novel protein SamCystin is associated with polycystic kidney disease in (cy\/+) rat","volume":"16","author":"JH Brown","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"F1034","DOI":"10.1152\/ajprenal.00195.2003","article-title":"Murine models of polycystic kidney disease: molecular and therapeutic insights","volume":"285","author":"LM Guay-Woodford","year":"2003","journal-title":"Am J Physiol Renal Physiol"},{"issue":"Suppl 6","key":"ref11","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/ndt\/11.supp6.46","article-title":"Rat models of autosomal dominant polycystic kidney disease","volume":"11","author":"N Gretz","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/sj.ki.5000049","article-title":"Differential regulation of metzincins in experimental chronic renal allograft rejection: potential markers and novel therapeutic targets","volume":"69","author":"CC Berthier","year":"2006","journal-title":"Kidney Int"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1093\/ndt\/gfm697","article-title":"Sirolimus ameliorates the enhanced expression of metalloproteinases in a rat model of autosomal dominant polycystic kidney disease","volume":"23","author":"CC Berthier","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/ki.2013.199","article-title":"Targeting of sodium-glucose cotransporters with phlorizin inhibits polycystic kidney disease progression in Han:SPRD rats","volume":"84","author":"X Wang","year":"2013","journal-title":"Kidney Int"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/ki.1996.445","article-title":"Chloride and fluid secretion by cultured human polycystic kidney cells","volume":"50","author":"DP Wallace","year":"1996","journal-title":"Kidney Int"},{"key":"ref16","article-title":"Estimating the safe starting dose in clinical trials for therapeutics in adult healthy volunteers","year":"2002"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00280-012-2045-1","article-title":"A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors","volume":"71","author":"LE Raez","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrc2981","article-title":"Regulation of cancer cell metabolism","volume":"11","author":"RA Cairns","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1093\/ndt\/gft521","article-title":"Defective metabolism in polycystic kidney disease: potential for therapy and open questions","volume":"29","author":"I Rowe","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"ref20","article-title":"2-Deoxy-d-Glucose Ameliorates PKD Progression","author":"M Chiaravalli","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1101\/gad.1756509","article-title":"Tumor suppressors and cell metabolism: a recipe for cancer growth","volume":"23","author":"RG Jones","year":"2009","journal-title":"Genes Dev"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"MG Vander Heiden","year":"2009","journal-title":"Science"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1158\/0008-5472.613.65.2","article-title":"Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia","volume":"65","author":"RH Xu","year":"2005","journal-title":"Cancer Research"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"F367","DOI":"10.1152\/ajprenal.00571.2013","article-title":"Mitochondrial dysfunction in the pathophysiology of renal diseases","volume":"306","author":"R Che","year":"2014","journal-title":"American journal of physiology Renal physiology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1002\/pmic.201100590","article-title":"Comparative proteomic analysis suggests that mitochondria are involved in autosomal recessive polycystic kidney disease","volume":"12","author":"QW Li","year":"2012","journal-title":"Proteomics"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"830","DOI":"10.2353\/ajpath.2007.060455","article-title":"Involvement of hypoxia-inducible transcription factors in polycystic kidney disease","volume":"170","author":"WM Bernhardt","year":"2007","journal-title":"The American journal of pathology"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1681\/ASN.2013030209","article-title":"Hypoxia-inducible factor-1alpha causes renal cyst expansion through calcium-activated chloride secretion","volume":"25","author":"B Buchholz","year":"2014","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1056\/NEJM199507063330104","article-title":"Apoptosis and loss of renal tissue in polycystic kidney diseases","volume":"333","author":"D Woo","year":"1995","journal-title":"N Engl J Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1046\/j.1523-1755.2002.00250.x","article-title":"Caspases, Bcl-2 proteins and apoptosis in autosomal-dominant polycystic kidney disease","volume":"61","author":"T Ecder","year":"2002","journal-title":"Kidney Int"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1084\/jem.183.4.1533","article-title":"Mitochondrial control of nuclear apoptosis","volume":"183","author":"N Zamzami","year":"1996","journal-title":"J Exp Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1096\/fasebj.13.9.1055","article-title":"Oxidative damage to mitochondrial DNA and glutathione oxidation in apoptosis: studies in vivo and in vitro","volume":"13","author":"JM Esteve","year":"1999","journal-title":"FASEB J"},{"key":"ref32","first-page":"1098","article-title":"Effects of 2-deoxyglucose on carbohydrate metablism: review of the literature and studies in the rat","volume":"11","author":"J Brown","year":"1962","journal-title":"Metabolism"},{"issue":"Spec No 1","key":"ref33","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/gerona\/56.suppl_1.20","article-title":"Caloric restriction mimetics: metabolic interventions","volume":"56","author":"R Weindruch","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s00280-003-0724-7","article-title":"Greater cell cycle inhibition and cytotoxicity induced by 2-deoxy-D-glucose in tumor cells treated under hypoxic vs aerobic conditions","volume":"53","author":"JC Maher","year":"2004","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/0008-5472.CAN-03-3294","article-title":"2-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo","volume":"64","author":"G Maschek","year":"2004","journal-title":"Cancer Research"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00066-005-1320-z","article-title":"Optimizing cancer radiotherapy with 2-deoxy-d-glucose dose escalation studies in patients with glioblastoma multiforme","volume":"181","author":"D Singh","year":"2005","journal-title":"Strahlenther Onkol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0360-3016(96)85017-6","article-title":"Improving cancer radiotherapy with 2-deoxy-D-glucose: phase I\/II clinical trials on human cerebral gliomas","volume":"35","author":"BK Mohanti","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.molcel.2008.04.012","article-title":"AMPK and Raptor: matching cell growth to energy supply","volume":"30","author":"DG Hardie","year":"2008","journal-title":"Molecular cell"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrm2672","article-title":"Molecular mechanisms of mTOR-mediated translational control","volume":"10","author":"XM Ma","year":"2009","journal-title":"Nature reviews Molecular cell biology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0146654","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T23:07:53Z","timestamp":1748732873000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0146654"}},"subtitle":[],"editor":[{"given":"Eric","family":"Feraille","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,1,11]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,1,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0146654","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,11]]}}}